HRS 2020: New Trial Data Support Medtronic’s Micra Pacemaker
The Micra CED study showed a lower rate of complications with the Micra leadless pacemaker than transvenous single-chamber pacemakers.
You may also be interested in...
About a month after it approved Abbott’s Aveir VR leadless pacemaker, the FDA approved two new models of Medtronic’s Micra leadless pacemaker.
The US Food and Drug Administration has issued a warning to clinicians of the heightened risk for adverse events, including death, from potential cardiac perforation during implantation of Medtronic’s Micra Transcatheter Pacing System (TPS).
June, July and August brought a number of important new approvals and trial announcements from the major cardiac device companies. Here are some of the highlights you might have missed during the summer.